Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Clinical Lab Management › LabCorp Expands Companion Dx Agreement With BML

LabCorp Expands Companion Dx Agreement With BML

Nov 02, 2020
|
staff reporter

NEW YORK – Laboratory Corporation of America said on Sunday that it had expanded its companion diagnostics development and commercialization agreement with Japanese clinical lab testing firm BML.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

What's Popular?

In Cancer

  1. Abviris Developing Blood-Based Serology Test For HPV-Related Cancers

    Premium

  2. Tempus Gets CE Mark for xT Tumor Sequencing Assay

  3. FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic

  4. Burning Rock Adds New Data Supporting Cancer Screening Liquid Biopsy, Automated NGS Products

    Premium

  5. Three Investment Banks Initiate Coverage of Biodesix

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.